Keyence Corporation

Ono Pharmaceutical Co., Ltd.

Shinya Takahashi

Jun Takeuchi

Takuya Seko

Yoshisuke Nakayama

Satoshi Itadani

Manabu Fujita

Tadashi Tatsumi

Takashi Suzuki

Masahiro Inomata

Woobum Kang

Masahiko Terakado

Kazuki Natori

Masao Naka

Yoshihisa Kamanaka

Kengo Yanase

Tsuyoshi Suenaga

Wataru Kamoshima

Hiroshi Kohno

A shape measuring apparatus includes a stage, a light projecting portion, a light receiving portion, and a rotation unit. The rotation unit is attached to an end of the stage. The rotation unit rotates the measurement subject about a rotation axis that vertically intersects while holding the measurement subject. In a state where the measurement subject is at a predetermined rotation angular position, the pattern light is emitted from the light projecting portion to the measurement subject a plurality of times while being phase-shifted. At this time, the light receiving portion captures an image of the measurement subject. Three-dimensional shape data is generated on the basis of a plurality of pieces of image data obtained by imaging.

Three-dimensional shape measuring apparatus

A shape measuring device includes a stereoscopic-shape-data generating sectionconfigured to generate stereoscopic shape data indicating a shape of the measurement object with a pattern projection method, a measurement-setting automatically adjusting sectionconfigured to automatically adjust measurement setting for the partial regions on the basis of at least one of stereoscopic shape data of the partial regions and light reception data acquired in the partial regions when the stereoscopic shape data is generated, and a stereoscopic-shape-data coupling sectionconfigured to couple, according to the measurement setting for the partial regions adjusted by a measurement setting adjusting section, the stereoscopic shape data of the partial regions generated again by the stereoscopic-shape-data generating sectionand generate coupled stereoscopic shape data corresponding to the coupled region.

Shape measuring device and shape measuring method

Provided are a measurement target measuring method, and a magnifying observation device which make it possible to readily and intuitively recognize a deviation between actual height image data and CAD data concerning a specific portion of a measurement target. A CAD height data generation unit generates a plurality of pieces of CAD height data based on basic CAD data. A reference height data selection unit selects reference height data from the plurality of pieces of CAD height data. A reference appearance image data acquisition unit acquires a reference appearance image corresponding to the reference height data. A target image display unit displays a target image based on texture image data or actual height image data, and a reference image display unit displays a reference image based on the reference appearance image data or the reference height data.

Measurement target measuring program, measurement target measuring method, and magnifying observation device

Provided is an image inspection device, an image inspection method and an image inspection program which are capable of easily and accurately inspecting a shape of an inspection target. In a setting mode, positioning image data of a setting target placed on a stage is registered. In an inspection mode, a positioning image is displayed on a display part based on the positioning image data. An image for positioning of the inspection target placed on the stage is displayed in the display part. Thereafter, image data for alignment of the inspection target is acquired, and then aligned to image data for alignment of the setting target. A size in a height direction of a measurement target place of the inspection target is measured based on the aligned height image data, to determine Pass/Fail of the inspection target. The determined determination result is displayed on the display unit.

Image inspection device, image inspection method and image inspection program

An image with a wide visual field can be captured without causing deterioration in measurement accuracy. There are provided: a stage on which an object is placed; a display unit for displaying a height image or an observation image; a measurement unit for performing measurement on the height image; an image connecting unit configured to, by moving the stage and capturing a different region, acquire a plurality of height images, and connect the obtained plurality of height images and observation images to generate a connected image; a measurement error region display unit configured to superimpose and display a measurement error region, on an image of the object; and a measurement-image imaging condition setting unit for adjusting an imaging condition for a striped image required for generation of the height image to reduce the measurement error region.

Measurement microscope device, image generating method, measurement microscope device operation program, and computer-readable recording medium

The invention provides an image processing device, an image processing method, and an image processing program, which enable immediately and easily searching for images showing certain states of subjects. Image data of a plurality of frames for displaying images of the plurality of frames, and a plurality of evaluation values associated with the image data of the plurality of frames are stored in a storage unit. The image data of a frame is selected, out of the stored image data of the plurality of frames. The images based on the image data of the respective frames are displayed. A thumbnail image corresponding to the image data of the selected frames is displayed in a thumbnail display area in the display unit. If a thumbnail image is selected, an image of a frame corresponding to this thumbnail image is displayed.

Image processing device, image processing method, and image processing program

The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLTand therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.

Substituted indole derivatives for the treatment of respiratory diseases

To provide a high speed photographic device which can display in real time a synchronous image photographed in synchronization with motion of a photographic subject. The high speed photographic device (), which displays in real time a photography image which is in synchronization with a motion cycle of the photographic subject TG, includes: a synchronous cycle adjustment unit () which is for designating a synchronous cycle Tsync; a camera () which photographs the photographic subject TG at a photography cycle Tshot that is 1/N as long as the synchronous cycle Tsync; and a display unit () which displays in real time the photographic subject TG by displaying the photography image of every synchronous cycle Tsync every display cycle Tdisp. The synchronous cycle adjustment unit () can adjust the synchronous cycle Tsync at a step width &#x394;Tsync smaller than a visual minimum cycle, within an adjustment range which does not include less than the visual minimum cycle.

High speed photographic device, method for controlling high speed photographic device, and computer program

Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases

Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV etc.), sensitizers in treating cancer and immunosuppressants.

Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient

Compounds represented by formula (I), prodrugs thereof and salts thereof, and pharmaceutical compositions comprising the same as an active ingredient (wherein each symbol has the meaning as defined in the specification.). Because of having an EDG-1 agonism, the compounds represented by formula (I) are useful in preventing and/or treating peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid, anal fissure or fistula ani, dissecting aneurysm of the aorta, angina, DIC, pleuritis, congestive heart failure, multiple organ failure, bedsore, burn, chronic ulcerative colitis, Crohn's disease, heart transplantation, renal transplantation, dermal graft, liver transplantation, osteoporosis, pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, liver cirrhosis, chronic renal failure, or glomerular sclerosis.

Carboxylic acid derivatives and drugs containing the same as the active ingredient

Poly(ADP-ribose)polymerase inhibitors containing as the active ingredient 2H-phthalazin-1-one derivatives represented by general formula (I) (wherein each symbol is as defined in the description) or salts thereof. The compounds of the general formula (I) inhibit poly(ADP-ribose)polymerase and are useful as preventives and/or remedies for various ischemic diseases (brain, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory intestinal diseases, multiple encephalosclerosis, arthritis, etc.), nerve degeneration diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, etc.), diabetes, shock, head trauma, renal insufficiency, hyperalgesia, etc. These compounds are also useful as sensitizers for agents against retroviruses (HIV, etc.) and chemotherapy for cancer.

Growing community of inventors

Osaka, Japan

Shinya Takahashi